LIRAGLUTIDE
Liraglutide is a synthetic 34-amino acid analog of human glucagon-like peptide-1 (GLP-1), structurally modified with a C16 fatty acid chain to extend receptor binding duration and plasma stability. Supplied as a lyophilized powder in a 3mL vial, it is intended exclusively for in vitro laboratory research by qualified scientific personnel.
This peptide has been utilized in preclinical studies examining GLP-1 receptor binding kinetics, glucose-dependent insulin secretion mechanisms, pancreatic beta cell function, and hepatic lipid metabolism signaling pathways — independent of the broader metabolic effects associated with endogenous GLP-1 activity.
Product Details
- Form: Lyophilized powder (for laboratory research)
- Amounts: 5mg per vial
- Purity: ≥ 98% (HPLC tested)
- Sequence: 31-amino-acid GLP-1 analogue (modified with a C-16 fatty acid chain for stability)
- Molecular Formula: C₂₀₇H₃₁₁N₅₁O₆₄
- Molecular Weight: ~3751.2 g/mol
- Intended Use: Laboratory research only
DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.
We recommend you review our Terms of Service if you have questions about product use.
